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Introduction
Portal hypertension is characterized by decreased vas-
cular resistance and increased blood flow in the splanch-
nic and systemic circulation in humans and experimental
models.1,2 Decreased vascular reactivity to vasopressors
(e.g. phenylephrine, vasopressin, or angiotensin II) is
mainly due to overproduction of vasodilators.3–6 Nitric
oxide (NO) is the main vasodilator that is overpro-
duced.7,8 Pharmacological treatment frequently fails
to control acute esophageal varices bleeding in patients
with infections.9,10 During sepsis, it has been proposed
that response failure is due to more pronounced NO
production.11,12 Although impaired vascular reactivity
to vasopressors has been observed in septic rats,13,14
this phenomenon is not observed in portal hyperten-
sive rats after lipopolysaccharide (LPS) challenge.15
Cecum ligation and puncture (CLP) is a live polymi-
crobial sepsis model.16 The kinetics and magnitude of
cytokine production following CLP are significantly
different from those of LPS challenge.17 It is unknown
whether CLP-induced sepsis further elicits vascular
hyporesponsiveness in the portal hypertensive rat, which
already has blunted vascular reactivity caused by an
overproduction of NO. Therefore, we implemented
an animal model of sepsis superimposed on portal
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hypertension by performing CLP in rats with portal
vein ligation (PVL). The aim of this study was to eval-
uate vascular contractility in PVL rats following sepsis
induced by CLP. Based on previous reports that
imipenem effectively controls sepsis induced by CLP in
rats,18,19 we also administrated imipenem before CLP
to evaluate the effect of prophylactic antibiotics (ABX)
on vascular responsiveness in PVL rats with CLP.
Methods
Animals
The experiments were performed in male Sprague-
Dawley rats weighing 250–300g. The rats were housed
in Plexiglas cages with controlled temperature and
humidity and were allowed free access to water and rat
chow (Ralston Purina Co., St. Louis, MO, USA). The
rats were anesthetized with ketamine hydrochloride
(100 mg/kg body weight, intraperitoneal injection).
After a midline incision was made, the portal vein was
isolated and stenosis was created by means of a single
ligature placed around both the portal vein and a blunt-
ended 20-gauge needle. The needle was then removed,
leaving a calibrated stenosis of the portal vein (PVL).20,21
In sham-operated animals, the portal vein was isolated,
but no ligature was placed. The abdomen was then
closed. Sham-operated rats were used as controls. After
the operation, the animals were housed in plastic cages
and allowed free access to rat food and water until 24
hours before CLP.
CLP
Fourteen days after PVL, the rats were anesthetized
with ketamine hydrochloride (100mg/kg body weight,
intraperitoneal injection). An incision 2–3 cm long was
made in the peritoneal cavity to expose the cecum. The
cecum was ligated with 3-0 silk suture without occlud-
ing the lumen of the small or large bowel. A 19-gauge
needle was then used to puncture the ligated cecum
twice, which resulted in 4 holes in the cecum. A small
amount of feces was gently expressed into the peritoneal
space. The cecum was returned to the peritoneal cavity,
and the incision was closed in 2 layers with a 3-0 silk
running suture. Immediately after the procedure, the
rats received 5 mL/100 g of normal saline subcuta-
neously and dorsally for resuscitation.16
Hemodynamic studies
In polymicrobial sepsis induced by CLP, the hemody-
namic changes are characterized by an early, hyper-
dynamic phase (i.e. 2–10 hours) followed by a late,
hypodynamic phase (greater than 16 hours).22–24
Although the hemodynamic changes occur as early as 2
hours after CLP, profound NO production by inducible
NO synthase (iNOS) begins 5–6 hours after CLP.25–27
During the late phase, most parameters including mean
arterial pressure, heart rate, and body temperature are
lowest at 18 hours after CLP.24 In our preliminary
study, all animals were dead 24 hours after CLP.
Therefore, rats that survived PVL were divided into 3
groups in which the experiments were performed 2,
6, and 18 hours after CLP: PVL + CLP2 (n = 8, begin-
ning of early sepsis), PVL + CLP6 (n = 8, beginning of
NO production), and PVL + CLP18 (n = 8, late phase
of sepsis). The rats were anesthetized with ketamine
hydrochloride (100 mg/kg body weight, intraperi-
toneal injection). The femoral artery was cannulated
with a PE-50 catheter, which was then attached to a
pressure transducer for the measurement of mean arte-
rial pressure.28 The abdomen was then opened. Portal
vein pressure was measured indirectly with direct
splenic puncture (splenic pulp pressure). Sterile swabs
were passed over the parietal peritoneum and plated.
Hemodynamic studies were also performed in sham-
operated rats (n = 8), which served as normal controls,
and in PVL rats without CLP (n=8) as portal hyperten-
sive controls. At completion of the baseline hemody-
namic measurement, the superior mesenteric artery was
carefully excised for vascular ring studies. Blood samples
(2mL) from the femoral arterial catheter were collected
into blood culture bottles. The remaining samples were
collected into chilled, heparinized test tubes, which
were then immediately centrifuged at 3,000rpm at 4°C
for 20 minutes. The supernatant was frozen for subse-
quent measurement of serum NO concentrations.29
Isolated vascular ring studies
The superior mesenteric artery from each rat was cut
into 5-mm rings. The rings were then mounted
between 2 stainless steel wires in a 15-mL jacketed
organ chamber containing modified Krebs solution
(0.12 mol/L NaCl, 4.7 mmol/L KCL, 2.4 mmol/L
MgSO4, 1.2 mmol/L KH2PO4, 11 mmol/L glucose,
25 mmol/L NaHCO3, and 1.25 nmol CaCl2 bubbled
with 95% O2 and 5% CO2 at 37°C). After equilibration,
the vascular rings were stretched with an initial pas-
sive force of 1 g. One wire was fixed to a brass manipu-
lator and the other was attached to an isometric force
transducer (model FT 03; Grass Instruments Co.,
Quincy, MA, USA) and a polygraph (models 7 and
7E; Grass Instruments Co.) for the continuous record-
ing of tension. Eight vascular rings were examined in
parallel. After the rings were equilibrated for 90 min-
utes, KCl (0.6 M) was added to the tissue bath to
check tissue viability. The presence of endothelium was
J Chin Med Assoc • September 2010 • Vol 73 • No 9464
W.C. Liao, et al
confirmed by the addition of acetylcholine (10μmol/L).
The drug was washed out and the tissue was allowed
to return to a baseline level. The cumulative dose-
response curve of phenylephrine (10–11 to 10–5 M) was
then determined. The vessels were washed extensively
before adding the NOS inhibitor N-nitro-L-arginine
methyl ester (L-NAME; final concentration, 100 μmol/
L) for 20 minutes,29 the iNOS inhibitor 1400W (N-
(3-(aminomethyl)benzyl) acetamidine hydrochloride;
final concentration 30 μmol/L) for 30 minutes, and a
combination of both L-NAME and 1400W.30 Deter-
mination of the cumulative dose-response curves for
phenylephrine (10–11 to 10–5 M) was repeated. The
tissue viability was again checked with KCl (0.6 M) at
the end of the experiment. The vessel rings were then
dried for 24 hours and weighed. The force of vascular
contraction was standardized by tissue weight.29
Microbiological study
For blood cultures, 1 mL of blood was inoculated in
standard blood culture bottles for aerobic and anaer-
obic microorganisms and then incubated in the corre-
sponding automated system (BacT/Alert; Organon
Teknica Corp., Durham, NC, USA). For peritoneal cul-
ture, samples were collected by passing a sterile swab
over the peritoneum and then inoculated on a bi-plate
containing sheep blood agar, eosin methylene blue
medium and Brucella agar. The bi-plate was incubated
at 37°C for 48 hours for aerobic microorganisms. The
Brucella agar was incubated under anaerobic condi-
tions in an anaerobic jar (Anaerocult A; Merck Ltd.,
Darmstadt, Germany). Subsequent identification of the
bacterial isolates in positive cultures was performed
according to standard microbiological methods.31
Effect of ABX
To study the effect of ABX, a single dose of imipenem
was given (10 mg intravenously) to a selected group
of rats 1 hour before CLP (PVL + ABX + CLP6). The
hemodynamic study, microbiology study, and isolated
vascular ring study were performed 6 hours after
CLP.
Measurement of plasma NO
Plasma concentrations of stable NO were measured
using colorimetric assays (Caymen Chemicals, Ann
Arbor, MI, USA). In serum, the final products of NO
in vitro are nitrite (NO2−) and nitrate (NO3−). In brief,
the nitrate in the sample was reduced to nitrite by adding
nitrate reductase. The nitrite was converted to a deep
purple azo compound with the addition of a Greiss
reagent and subsequently measured by spectrophotom-
etry (Bio-Tek EL331 Microplate Autoreader; Bio-Tek,
Winooski, VT, USA) at 550 nm.14
Statistical analysis
Continuous variables were expressed as group medi-
ans (range) and compared between groups using a
Wilcoxon 2-sample test or Kruskal-Wallis nonpara-
metric test. Data used to plot dose-response curves
were the median (range) contraction induced at each
concentration of the drug. The dose-response curves
were compared by the extra sum of squares F test of
EC50:(logM). Categorical variables were examined
using Fisher’s exact test. Significance was set at
p < 0.05. Statistical and graphical analyses were carried
out using PRISM 5 (2006; GraphPad Software Inc.,
San Diego, CA, USA) for Windows.
Results
Hemodynamic studies
Hemodynamic data are shown in Table 1. After 14
days of PVL, portal hypertension was evident as shown
by significantly elevated splenic pulp pressure. Mean
Table 1. Hemodynamics of sham and portal vein-ligated rats and rats with intra-abdominal sepsis*†
Group MAP (mmHg) HR (bpm) PP (mmHg)
Sham (n = 8) 125.76 (120.37–136.20) 325.5 (222.0–378.7) 6.94 (5.59–7.94)
PVL (n = 8) 110.60 (96.80–118.20) 404.0 (358.9–404.0) 13.75 (12.0–16.0)
PVL + CLP2 (n = 8) 89.15 (82.00–100.30) 290.6 (268.3–374.4) 15.89 (12.57–15.47)
PVL + CLP6 (n = 8) 82.05 (63.70–91.60) 293.5 (291.6–358.0) 16.51 (14.12–22.64)
PVL + CLP18 (n = 8) 70.52 (58.50–72.68) 278.0 (232.1–372.1) 14.89 (12.06–19.71)
PVL + ABX + CLP6 (n = 8) 77.18 (68.10–77.20) 289.9 (256.3–322.1) 16.51 (14.12–22.64)
*Data are presented as median (range); †CLPx hemodynamic study was performed x hours after cecum ligation and puncture. MAP = mean arterial pressure;
HR = heart rate; PP = pulp pressure; PVL = portal vein ligation; CLP = cecum ligation and puncture; ABX = antibiotics.
NOTES. (1) Results of PVL were compared with those of sham by Wilcoxon 2-sample test. Significant differences were found in MAP (p = 0.001), HR (p = 0.003),
and PP (p = 0.001) after PVL. (2) The values were compared within PVL + CLP groups by Kruskal-Wallis test, and there were significant differences in MAP
(p = 0.001) and HR (p = 0.003), but no significant differences in PP (p = 0.288), among groups. (3) There were no significant differences in MAP, HR and PP
between PVL + CLP6 and PVL + ABX + CLP6 by Wilcoxon 2-sample test.
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arterial pressure was significantly decreased and heart
rate was significantly increased after PVL. In portal
hypertensive animals that had received CLP (PVL +
CLP), both mean arterial pressure and heart rate were
significantly lower than those in PVL controls. The
splenic pulp pressures were not significantly different
between PVL rats with and without CLP. The hemo-
dynamics endpoints of PVL + CLP6 rats that had
received ABX (PVL + ABX + CLP6) were not signifi-
cantly different from those of rats that had not
received ABX.
Microbiological study
Laparotomy in the PVL + CLP group revealed a pale
necrotic cecum and 1–2 mL of cloudy fluid in the
peritoneum. Peritoneal cultures from these animals
were all positive. Most peritoneal cultures grew mixed
microorganisms, mainly Escherichia coli, Klebsiella
spp., Enterococcus spp., Lactobacillus spp., Bacillus
spp., and Bacteroides fragilis. Blood cultures obtained
from these animals were all positive. The blood cul-
ture rate was significantly lower in the ABX group
(PVL + ABX + CLP6) compared with the PVL +
CLP6 group (culture rate: 8/8 vs. 2/8; p = 0.007).
However, ABX did not produce a statistically differ-
ent peritoneal culture rate (culture rate: 8/8 vs. 6/8;
p = 0.233).
Isolated vascular ring studies
The contractile response of the superior mesenteric ar-
tery in PVL rats is shown in Figure 1. A significant vas-
cular hyporesponsiveness to phenylephrine was observed
in PVL controls rats compared with sham-operated
rats (Figure 1A). Treatment with L-NAME + 1400W
resulted in a shift to the left in the dose-response curves
of sham-operated rats. The sham + L-NAME and
sham + L-NAME + 1400W groups had a significantly
higher maximal contraction than the sham alone group
[maximal contraction (g): sham + L-NAME vs. sham:
4.40 (3.38–4.67) vs. 3.85 (3.51–4.34), p < 0.001;
sham + L-NAME + 1400W vs. sham: 4.28 (3.86–4.30)
vs. 3.85 (3.51–4.34), p<0.001]. The 1400W alone did
not alter the dose-response curves of sham-operated rats
(Figure 1B). After incubation with L-NAME + 1400W,
but not 1400W alone, comparison of the dose-response
curves for sham and PVL controls showed no signifi-
cant difference (Figure 1C). The PVL + 1400W group
had a significantly lower maximal contraction than the
sham [maximal contraction (g): sham vs. PVL+1400W:
3.85 (3.51–4.34) vs. 3.15 (2.70–3.64), p = 0.001].
These results indicate that vascular hyporesponsive-
ness to phenylephrine in PVL rats could be corrected
by L-NAME, but not by 1400W.
Contractile response in PVL rats after CLP
The dose-response curves were not significantly differ-
ent between PVL control (without CLP) and PVL +
CLP2 rats (Figure 2A). However, 6 and 18 hours
after CLP (PVL + CLP6 and PVL + CLP18), the dose-
response curves for the superior mesenteric artery were
significantly lower than those in the PVL controls. These
results indicate that the vascular response to phenyle-
phrine in PVL starts to be attenuated 2–6 hours after
CLP-induced sepsis.
Effects of NOS inhibition and ABX
After incubation with L-NAME with or without
1400W, the dose-response curves for PVL + CLP2 rats
shifted to the left, and vascular contractility was restored
to that of PVL controls treated with L-NAME (Figure
2B). Incubation with 1400W alone did not alter the
vascular contractility of PVL + CLP2 rats. In PVL +
CLP6 and PVL + CLP18 rats, which already had fur-
ther impaired vascular contractility after CLP, the dose-
response curves also shifted to the left, but were still
lower than the curves for the PVL control rats treated
with L-NAME or 1400W alone (Figures 2C and 2D).
The dose-response curves shifted even further to the
left following incubation with L-NAME and 1400W
(PVL+CLP6+L-NAME+1400W vs. PVL+CLP6+L-
NAME, p=0.031; PVL+CLP18+L-NAME+1400W
vs. PVL + CLP18 + L-NAME, p = 0.006). L-NAME
combined with 1400W also restored the contractility
of PVL + CLP6 rats to that observed for PVL controls
treated with L-NAME. Although the dose-response
curves of PVL + CLP18 rats also shifted further to the
left after incubation with a combination of L-NAME
and 1400W, they were still lower than those of PVL
controls treated with L-NAME alone. The dose-
response curve of PVL + ABX + CLP6 rats showed no
significant difference compared with the dose-response
curve of PVL + CLP6 rats (PVL + CLP6 vs. PVL +
ABX + CLP6, p = 0.58; Figure 3).
Effects of PVL and CLP on plasma 
NO3-/NO2-
PVL caused a significant increase in plasma NO3−/
NO2− concentrations. Two hours after the onset of
sepsis induced by CLP in PVL rats, there was no addi-
tional increase in plasma NO3−/NO2− concentrations
compared with the PVL control rats. Six hours after
CLP in PVL rats, plasma NO3−/NO2− concentrations
increased further. The increase in plasma NO3−/
NO2− concentrations persisted for 18 hours following
CLP (Figures 4 and 5). ABX did not cause a decrease
in plasma NO3−/NO2− concentrations 6 hours after
CLP.
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Figure 1. Dose-response curves of phenylephrine-induced contraction of the superior mesentery artery in portal vein-ligated (PVL) and
sham-operated rats: (A) before; and (B, C) after incubation with N-nitro-L-arginine methyl ester (L-NAME) and 1400W.
Discussion
In the current study, hyporesponsiveness to phenyle-
phrine in PVL rats was corrected with the use of a non-
selective NOS inhibitor (L-NAME), which is consistent
with previous studies.7,8 We found that the dose re-
sponse curves of the sham + L-NAME or sham + L-
NAME + 1400W groups were significantly higher than
that of the sham group (Figure 1B). The hyperresponsive
reaction resulted from existing physiological eNOS
blocked by L-NAME. This result is compatible with
that of a previous study.32 For more than 6 hours after
CLP, vascular contractility was further impaired in
portal hypertensive rats. Vascular hyporesponsiveness
improved after incubation with L-NAME. These results
indicate that a more pronounced NO production
occurred in PVL rats than in sham-operated rats, which
is consistent with previous non-portal hypertensive
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studies.22 This observation is supported by the finding
of increased plasma concentrations of NO3−/NO2− 6
hours after initiation of CLP, which is also consistent
with previous studies.33 However, we found that the
dose-response curves for PVL + CLP6 and PVL +
CLP18 rats treated with L-NAME were still lower than
those of PVL controls treated with L-NAME. A pos-
sible explanation for partial correction by L-NAME is
that there was incomplete iNOS inhibition or involve-
ment of mediators other than NO in the CLP-induced
vascular hyporesponsiveness in PVL rats. We examined
the former possibility with the potent and highly selec-
tive iNOS inhibitor 1400W. We found that L-NAME
combined with 1400W almost completely restored
vascular contractility in early sepsis in PVL rats. This
observation provided further support for augmented
NO overproduction by iNOS resulting in further 
vascular hyporesponsiveness in PVL rats after CLP. In
the later stage of sepsis in PVL rats, contractility of 
the superior mesentery artery was strengthened by the
combination of L-NAME and 1400W, but it was still
lower than that observed for the PVL controls. In both
the present and previous non-portal hypertensive
studies, CLP caused a significant increase in plasma
NO3−/NO2− concentrations during early sepsis. We
found that iNOS activity reached its maximum at the
end of early sepsis, and there was no additional in-
crease in plasma NO3−/NO2− during late sepsis. These
findings indicate that factors other than NO, such as
direct muscle injury, may be involved in CLP-induced
hyporesponsiveness in PVL rats during late sepsis.23
However, Heller et al15 showed that in vitro vascu-
lar reactivity in the aorta of PVL rats did not decrease
5 hours after LPS administration. They found that
because baseline NO overproduction by eNOS can
inhibit iNOS activity after LPS administration, further
impairment of vasoreactivity has not been observed in
LPS-administered portal hypertensive rats. A high
concentration of tumor necrosis factor-α might pre-
vent the inhibition of iNOS induction by the aortic
endothelium in portal hypertensive rats.34 In the LPS-
challenged sepsis model, the tumor necrosis factor-α
concentration peaks between 1.5 and 4 hours and
declines thereafter.35 In contrast, the tumor necrosis
factor-α concentration in the CLP model continues
to increase at the 8-hour time point.35 The different
pharmacokinetics of cytokines and vascular types (supe-
rior mesentery artery in our study and thoracic aorta
(Contd)
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Figure 2. (A) Dose-response curves of phenylephrine-induced contractility of the superior mesentery artery in portal vein-ligated (PVL)
rats before and 2, 6, and 18 hours after cecum ligation and puncture (CLP). Dose-response curves of phenylephrine-induced contrac-
tion of the superior mesentery in PVL rats. (B) 2 hours, (C) 6 hours, and (D) 18 hours after CLP before and after incubation with N-nitro-
L-arginine methyl ester (L-NAME) and 1400W.
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Figure 3. Dose-response curves of phenylephrine-induced con-
tractility of the superior mesentery artery in portal vein-ligated
(PVL) rats 6 hours after cecum ligation and puncture (CLP) with or
without antibiotics (ABX) 1 hour before CLP.
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Figure 4. Plasma concentrations of NO3−/NO2− in sham-operated
and portal vein-ligated (PVL) rats before (control) and 2, 6, and 
18 hours after cecum ligation and puncture (CLP) in PVL rats.
Data are expressed as the median with range. *p < 0.05 vs.
sham-operated; †p < 0.05 vs. PVL.
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in Heller et al’s study) could be possible reasons for the
discrepancy between the present model and Heller 
et al’s model. In contrast with the LPS challenge,
CLP induces infection and local inflammation, which
is soon accompanied by a cascade of systemic patho-
physiological and immunological reactions. Gram-
positive bacteria also cause a significant number of
infections in cirrhotic patients.36,37 Gram-positive and
Gram-negative bacteremia more appropriately resem-
ble a real infection in portal hypertensive patients in 
a CLP model than in an LPS-challenged model, in
which only part of the cell wall component of Gram-
negative bacteria is injected into the circulation.
Patients with portal hypertension and gastroin-
testinal bleeding are particularly susceptible to bacter-
ial infection.38–40 In portal hypertension patients,
bacterial infection is independently associated with a
failure to control bleeding, despite active treatment
with vasoconstrictors such as terlipressin or somato-
statin.39 Infection-induced NO overproduction has
been suggested to possibly be a trigger of early variceal
rebleeding through its antiplatelet effects.38 Based on
the current observation of superior mesentery artery
hyporesponsiveness in septic PVL rats in vitro, we
postulate that NO may have another role in the fail-
ure of pharmacological control of variceal bleeding in
infected patients through a reduction in the respon-
siveness of the superior mesentery artery to vasoactive
agents.
In the current study, the amount of imipenem
administered (10mg intravenously 1 hour before CLP)
was based on a dose used in a previous study to prevent
intra-abdominal sepsis.19 However, in the current study,
ABX did not alter the peritoneal culture rate, hemo-
dynamic status, or sepsis-induced superior mesenteric
artery hyporesponsiveness. It is possible that the comor-
bid status of portal hypertension makes rats more vul-
nerable to infection despite ABX. A higher dose of
antibiotics and a longer duration of treatment (20 mg
imipenem injected intramuscularly 1 hour before CLP,
a second injection of 10 mg imipenem 2 hours after
infection, and then 10 mg imipenem every 8 hours for
3 days) was used in a previous study to prevent sepsis.18
Although the survival rate improved, peritoneal abscess
was still observed in 37% of the surviving animals.18
Therefore, it is not known whether a higher dose of
antibiotics for a longer time could prevent a sepsis 
cascade in portal hypertensive rats.
In conclusion, we observed that vascular reactivity
was further impaired soon after CLP-induced sepsis in
portal hypertensive rats. Vascular hyporesponsiveness
to vasoactive agents during sepsis should be taken into
account when attempting to explain bacterial infec-
tion as a poor prognostic factor for control of variceal
bleeding. However, further clinical studies are needed
to validate this hypothesis.
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